• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5078629)   Today's Articles (1395)
For: Vehmanen L, Saarto T, Elomaa I, Mäkelä P, Välimäki M, Blomqvist C. Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment. Eur J Cancer 2001;37:2373-8. [PMID: 11720830 DOI: 10.1016/s0959-8049(01)00317-3] [Citation(s) in RCA: 97] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Number Cited by Other Article(s)
51
Brufsky AM. The Evolving Role of Bone-Conserving Therapy in Patients With Breast Cancer. Semin Oncol 2010;37 Suppl 1:S12-9. [DOI: 10.1053/j.seminoncol.2010.06.002] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
52
Should bisphosphonates be utilized in the adjuvant setting for breast cancer? Breast Cancer Res Treat 2010;122:627-36. [DOI: 10.1007/s10549-010-0935-7] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2010] [Accepted: 05/03/2010] [Indexed: 10/19/2022]
53
Loo WTY, Jin LJ, Cheung MNB, Chow LWC, Wang M. Combination of radiological and biochemical methods to assess bone mineral density of mandible in fully edentulous patients after chemotherapy: a 5-year prospective study. Expert Opin Investig Drugs 2010;19 Suppl 1:S109-15. [DOI: 10.1517/13543781003727065] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
54
Bisphosphonates: ready for use as adjuvant therapy of breast cancer? Curr Opin Obstet Gynecol 2010;22:61-6. [DOI: 10.1097/gco.0b013e328334e43b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
55
Lack of evidence for fracture prevention in early breast cancer bisphosphonate trials: a meta-analysis. Gynecol Oncol 2010;117:139-45. [PMID: 20061004 DOI: 10.1016/j.ygyno.2009.12.001] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2009] [Revised: 11/23/2009] [Accepted: 12/02/2009] [Indexed: 11/20/2022]
56
New results from the use of bisphosphonates in cancer patients. Curr Opin Support Palliat Care 2009;3:213-8. [PMID: 19561507 DOI: 10.1097/spc.0b013e32832f4149] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
57
Gnant M. Adjuvant bisphosphonates in endocrine-responsive breast cancer: what is their place in therapy? Ther Adv Med Oncol 2009;1:123-36. [PMID: 21789117 PMCID: PMC3126000 DOI: 10.1177/1758834009344594] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]  Open
58
The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer. Eur J Cancer 2009;45:3205-12. [PMID: 19850468 DOI: 10.1016/j.ejca.2009.09.026] [Citation(s) in RCA: 57] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2009] [Accepted: 09/22/2009] [Indexed: 10/20/2022]
59
Bjarnason NH, Hitz M, Jorgensen NR, Vestergaard P. Adverse bone effects during pharmacological breast cancer therapy. Acta Oncol 2009;47:747-54. [PMID: 18465344 DOI: 10.1080/02841860802001467] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
60
Pecherstorfer M. Treatment Options for Breast Cancer and Bone Metastases. WOMENS HEALTH 2009;5:149-63. [DOI: 10.2217/17455057.5.2.149] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
61
Gnant M. The evolving role of zoledronic acid in early breast cancer. Onco Targets Ther 2009;2:95-104. [PMID: 20616898 PMCID: PMC2886321 DOI: 10.2147/ott.s4082] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2009] [Indexed: 11/23/2022]  Open
62
Saarto T. Adjuvant therapy of breast cancer - bisphosphonates. Cancer Treat Res 2009;151:163-177. [PMID: 19593512 DOI: 10.1007/978-0-387-75115-3_11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
63
Saad F, Adachi JD, Brown JP, Canning LA, Gelmon KA, Josse RG, Pritchard KI. Cancer treatment-induced bone loss in breast and prostate cancer. J Clin Oncol 2008;26:5465-76. [PMID: 18955443 DOI: 10.1200/jco.2008.18.4184] [Citation(s) in RCA: 130] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
64
Saarto T, Vehmanen L, Blomqvist C, Elomaa I. Ten-year follow-up of 3 years of oral adjuvant clodronate therapy shows significant prevention of osteoporosis in early-stage breast cancer. J Clin Oncol 2008;26:4289-95. [PMID: 18779616 DOI: 10.1200/jco.2007.15.4997] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]  Open
65
Bone mineral density and bone turnover in postmenopausal women treated for breast cancer. Cancer Nurs 2008;31:182-90. [PMID: 18453874 DOI: 10.1097/01.ncc.0000305722.75647.26] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
66
Vestergaard P. Adverse Effects of Drugs on Bone and Calcium Metabolism/Physiology. Clin Rev Bone Miner Metab 2008. [DOI: 10.1007/s12018-007-9002-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
67
Brufsky AM. Cancer treatment-induced bone loss: pathophysiology and clinical perspectives. Oncologist 2008;13:187-95. [PMID: 18305064 DOI: 10.1634/theoncologist.2007-0152] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]  Open
68
Greenspan SL, Brufsky A, Lembersky BC, Bhattacharya R, Vujevich KT, Perera S, Sereika SM, Vogel VG. Risedronate prevents bone loss in breast cancer survivors: a 2-year, randomized, double-blind, placebo-controlled clinical trial. J Clin Oncol 2008;26:2644-52. [PMID: 18427147 DOI: 10.1200/jco.2007.15.2967] [Citation(s) in RCA: 68] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
69
Olmos Martínez JM, González Macías J. [Osteoporosis in cancer survivors]. Med Clin (Barc) 2007;129:669-76. [PMID: 18005636 DOI: 10.1157/13112094] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
70
Monnier A. Clinical management of adverse events in adjuvant therapy for hormone-responsive early breast cancer. Ann Oncol 2007;18 Suppl 8:viii36-44. [PMID: 17890213 DOI: 10.1093/annonc/mdm264] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
71
Gralow JR. Bone Density in Breast Cancer: When to Intervene? J Clin Oncol 2007;25:3194-7. [PMID: 17577014 DOI: 10.1200/jco.2007.12.3430] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]  Open
72
Layman R, Olson K, Van Poznak C. Bisphosphonates for Breast Cancer: Questions Answered, Questions Remaining. Hematol Oncol Clin North Am 2007;21:341-67. [PMID: 17512453 DOI: 10.1016/j.hoc.2007.03.004] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
73
Stricker CT. Endocrine Effects of Breast Cancer Treatment. Semin Oncol Nurs 2007;23:55-70. [PMID: 17303517 DOI: 10.1016/j.soncn.2006.11.006] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
74
Greenspan SL, Bhattacharya RK, Sereika SM, Brufsky A, Vogel VG. Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab 2007;92:131-6. [PMID: 17047022 DOI: 10.1210/jc.2006-1272] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
75
BARNETT F, DE BOER R. Cancer treatment-induced bone loss: A review. Asia Pac J Clin Oncol 2006. [DOI: 10.1111/j.1743-7563.2006.00067.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
76
Hirbe A, Morgan EA, Uluçkan O, Weilbaecher K. Skeletal complications of breast cancer therapies. Clin Cancer Res 2006;12:6309s-6314s. [PMID: 17062720 PMCID: PMC2692197 DOI: 10.1158/1078-0432.ccr-06-0652] [Citation(s) in RCA: 70] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
77
Michaud LB, Goodin S. Cancer-treatment-induced bone loss, part 1. Am J Health Syst Pharm 2006;63:419-30. [PMID: 16484516 DOI: 10.2146/ajhp050045.p1] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]  Open
78
Vehmanen L, Elomaa I, Blomqvist C, Saarto T. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status. J Clin Oncol 2006;24:675-80. [PMID: 16446340 DOI: 10.1200/jco.2005.02.3515] [Citation(s) in RCA: 112] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]  Open
79
Body JJ. Bisphosphonates for malignancy-related bone disease: current status, future developments. Support Care Cancer 2006;14:408-18. [PMID: 16450087 DOI: 10.1007/s00520-005-0913-5] [Citation(s) in RCA: 62] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2005] [Accepted: 10/26/2005] [Indexed: 10/25/2022]
80
Burkinshaw R, Coleman R. Bisphosphonates as adjuvant therapy for breast cancer. WOMENS HEALTH 2006;2:115-26. [PMID: 19803932 DOI: 10.2217/17455057.2.1.115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
81
Lester J, Coleman R. Bone loss and the aromatase inhibitors. Br J Cancer 2005;93 Suppl 1:S16-22. [PMID: 16100521 PMCID: PMC2361688 DOI: 10.1038/sj.bjc.6602691] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]  Open
82
Rodríguez-Rodríguez LM, Rodríguez-Rodríguez EM, Oramas-Rodríguez JM, Santolaria-Fernandez F, Llanos M, Cruz J, Martínez A, González-Reimers E, Gómez A, Batista N. Changes on Bone Mineral Density after Adjuvant Treatment in Women with Non-metastatic Breast Cancer. Breast Cancer Res Treat 2005;93:75-83. [PMID: 16184462 DOI: 10.1007/s10549-005-3803-0] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
83
Saarto T, Taube T, Blomqvist C, Vehmanen L, Elomaa I. Three-year oral clodronate treatment does not impair mineralization of newly formed bone--a histomorphometric study. Calcif Tissue Int 2005;77:84-90. [PMID: 16075363 DOI: 10.1007/s00223-004-0262-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/17/2004] [Accepted: 03/30/2005] [Indexed: 10/25/2022]
84
Mystakidou K, Katsouda E, Stathopoulou E, Vlahos L. Approaches to managing bone metastases from breast cancer: The role of bisphosphonates. Cancer Treat Rev 2005;31:303-11. [PMID: 16039956 DOI: 10.1016/j.ctrv.2005.03.005] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
85
Theriault RL. Strategies to Prevent Chemotherapy-Induced Bone Loss in Women with Breast Cancer. Clin Breast Cancer 2005;5 Suppl:S63-70. [PMID: 15807926 DOI: 10.3816/cbc.2005.s.006] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
86
Crandall C, Petersen L, Ganz PA, Greendale GA. Bone mineral density and adjuvant therapy in breast cancer survivors. Breast Cancer Res Treat 2004;88:257-61. [PMID: 15609128 DOI: 10.1007/s10549-004-0804-3] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
87
Clemons M, Rea D. Perspectives on the future of bisphosphonate use in breast cancer patients. Semin Oncol 2004;31:87-91. [PMID: 15490383 DOI: 10.1053/j.seminoncol.2004.07.029] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
88
Vehmanen L, Saarto T, Risteli J, Risteli L, Blomqvist C, Elomaa I. Short-Term Intermittent Intravenous Clodronate in the Prevention of Bone Loss Related to Chemotherapy-Induced Ovarian Failure. Breast Cancer Res Treat 2004;87:181-8. [PMID: 15377842 DOI: 10.1023/b:brea.0000041624.00665.4e] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
89
Rule S. Managing cancer-related skeletal events with bisphosphonates. HOSPITAL MEDICINE (LONDON, ENGLAND : 1998) 2004;65:355-60. [PMID: 15222212 DOI: 10.12968/hosp.2004.65.6.13761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/30/2023]
90
Ramaswamy B, Shapiro CL. Osteopenia and osteoporosis in women with breast cancer. Semin Oncol 2003;30:763-75. [PMID: 14663777 DOI: 10.1053/j.seminoncol.2003.08.028] [Citation(s) in RCA: 96] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
91
Tanwani LK, Chudgar D, Murphree SS, Eblen AC, Mokshagundam SPL. A case of gonadal dysgenesis, breast development, Graves' disease, and low bone mass. Endocr Pract 2003;9:220-4. [PMID: 12917064 DOI: 10.4158/ep.9.3.220] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
PrevPage 2 of 2 12Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA